Our Company

ZEUS SCIENTIFIC DEVELOPS INNOVATIVE, HIGH QUALITY, AND COST-EFFECTIVE DIAGNOSTIC SOLUTIONS GEARED TOWARD THE ENHANCEMENT OF PATIENT CARE

Where we started

ZEUS Scientific is a privately held corporation that was founded in 1976. The company began producing IFA (immunofluorescence assay) test systems followed ELISA and now multiplex (AtheNA Multi-Lyte^®) immunoassays.

New products are developed to expand the menu which allows laboratories to run an increasing number of assays with common protocols and common reagents, as well as developing new tests to more accurately diagnose patients. In 1987 ZEUS Scientific was the first company to develop, receive appropriate regulatory clearance and bring to market a serological assay to test for Lyme disease – a condition with high prevalence in the local community where ZEUS Scientific is located.

What we believe in

ZEUS Scientific is dedicated to delivering the highest quality products to the diagnostic marketplace. ZEUS Scientific conforms to the applicable regulatory and international standards for in vitro diagnostic device manufacturers. The company has obtained over 130 product clearances from the FDA and the majority of the products also carry CE marking.

Where we are now

Our areas of expertise reside in diagnostic assays to aid in the diagnosis of autoimmune and infectious diseases. Across these disease states, ZEUS Scientific offers an industry leading menu of test kits, from our extensive selection of ZEUS ELISA and ZEUS IFA tests to technologically advanced platforms like the AtheNA Multi-Lyte^® Test System